CTOs on the Move

Smiths Medical

www.smiths-medical.com

 
Smiths Medical is a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the hospital, emergency, home and specialist environments. Our products are used during critical and intensive care, surgery, post-operative care during recovery, and in a series of home infusion therapies. We offer a number of some of the most respected and easily recognizable brands in the specialty device space: Portex™, Medex™, Deltec™, Level1™, Pneupac™, Wallace™, CADD™, BCI™, Jelco™, Medfusion™ and Surgivet™. Smiths Medical employs some 7,500 people, with manufacturing concentrated in the US, the UK, Mexico and Italy. Most territories are serviced through wholly-owned ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Philips

Royal Philips is a leading health technology company focused on improving people`s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips`​ health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries.

MicroAire

MicroAire is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

REZSTREAM

REZSTREAM is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Whiteside Biomechanics

Whiteside Biomechanics is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cytori

Cytori Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.